ANAL SQUAMOUS CELL CARCINOMA
Clinical trials for ANAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ANAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ANAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope drug enters human testing for Tough-to-Treat cancers
Disease control Recruiting nowThis is the first study in people testing a new drug called EVOLVE104. It aims to find a safe dose and see if it can help control advanced bladder and several types of squamous cell cancers. The study is for patients whose cancer has continued to grow despite standard treatments.
Matched conditions: ANAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: EvolveImmune United, Inc • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Tailored attack on HIV-Linked anal cancer tests gentler vs. stronger approach
Disease control Recruiting nowThis study is testing two personalized treatment plans for anal cancer in people living with HIV. For patients with low-risk cancer, researchers are testing a reduced dose of chemotherapy and radiation to see if it's effective with fewer side effects. For patients with high-risk …
Matched conditions: ANAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
MRI-Guided radiation tailors treatment to each Patient's risk
Disease control Recruiting nowThis study is testing a personalized approach to radiation therapy for anal cancer. Doctors will use MRI scans during treatment to guide radiation and adjust the dose based on each patient's specific risk level. The goal is to better control the cancer while trying to reduce side…
Matched conditions: ANAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Personalized daily radiation: a new aim for tough anal cancers
Disease control Recruiting nowThis small pilot study is testing whether adjusting a patient's radiation plan daily, based on how their tumor and body change, is a practical approach. The goal is to see if this method can better focus radiation on the shrinking tumor while reducing exposure to nearby healthy o…
Matched conditions: ANAL SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC